Evaluación del sistema de vigilancia de la tos ferina: avances y desafíos
Evaluation of the pertussis surveillance system: progress and challengesContenido principal del artículo
Introducción: La tos ferina es una enfermedad inmunoprevenible que afecta principalmente a lactantes no vacunados, representando un desafío para la salud pública que exige vigilancia epidemiológica efectiva. Objetivo: Evaluar el sistema de vigilancia de la tos ferina en Alto Paraná, Paraguay, analizando su comportamiento epidemiológico entre 2019 y 2023. Materiales y Método: Se realizó un estudio cuantitativo, descriptivo y transversal en dos fases: la primera analizó los casos notificados utilizando la base de datos del Programa Ampliado de Inmunizaciones; la segunda evaluó atributos cualitativos del sistema (simplicidad, aceptabilidad y utilidad) mediante encuestas a 110 médicos. Resultados: Se notificaron 66 casos sospechosos, con mediana de edad de 0,5 años y predominio en menores de un año (68,2%); 67% fueron hospitalizados, todos presentaron tos y 50% fiebre. La incidencia fue de 0,5 casos por 100.000 habitantes, superior a la nacional, con cobertura vacunal <80%. El 92% de los médicos percibió el sistema como regular; la utilidad fue el atributo mejor valorado (79%). Conclusiones: El sistema requiere fortalecimiento en vigilancia activa, simplificación operativa y mejora de coberturas vacunales para optimizar la detección temprana y el control de brotes.
Introduction: Whooping cough is a vaccine-preventable disease that primarily affects unvaccinated infants, representing a public health challenge that requires effective epidemiological surveillance. Objective: To evaluate the whooping cough surveillance system in Alto Paraná, Paraguay, analyzing its epidemiological behavior between 2019 and 2023. Materials and Method: A quantitative, descriptive, and cross-sectional study was conducted in two phases: the first analyzed reported cases using the Expanded Program on Immunization database; the second evaluated qualitative attributes of the system (simplicity, acceptability, and usefulness) through surveys of 110 physicians. Results: A total of 66 suspected cases were reported, with a median age of 0.5 years and a predominance in children under one year of age (68.2%); 67% were hospitalized, all had cough, and 50% had fever. The incidence was 0.5 cases per 100,000 inhabitants, higher than the national average, with vaccination coverage <80%. Ninety-two percent of physicians perceived the system as fair; usefulness was the most highly valued attribute (79%). Conclusions: The system requires strengthening active surveillance, operational simplification, and improved vaccination coverage to optimize early detection and outbreak control.
Descargas
Detalles del artículo
Organización Mundial de la Salud. Tos ferina. Ginebra: OMS; 2023. https://www.who.int/news-room/fact-sheets/detail/pertussis
Centers for Disease Control and Prevention. Pertussis (Whooping Cough): Clinical Features. Atlanta: CDC; 2023 [citado 18 mar 2024]. https://www.cdc.gov/pertussis/clinical/features.html
Organización Panamericana de la Salud. Guía para la vigilancia de la tos ferina (pertussis) en las Américas. Washington, D.C.: OPS; 2022. https://iris.paho.org/handle/10665.2/55847
Yeung H, Duclos P, Nelson A, Hutubessy C. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017;17(9):974-980. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30390-0/fulltext
Zouari A, Smaoui H, Brun D, Njamkepo E, Sghaier S, Felix R, et al. Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study. Diagn Microbiol Infect Dis. 2012;72(4):303-317. https://pubmed.ncbi.nlm.nih.gov/22277919/
van der Zee A, Vernooij S, Peeters M, van Embden J, Mooi F. Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology. 1996;142(12):3479-3485. https://www.microbiologyresearch.org/content/journal/micro/10.1099/13500872-142-12-3479
Plotkin, Stanley A., et al. Plotkin’s Vaccines. Seventh edition, Elsevier, 2018, https://doi.org/10.1016/C2013-0-18914-3.
Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367(11):1012-1019. https://www.nejm.org/doi/full/10.1056/NEJMoa1200850
Sheridan S, Frith K, Snelling T, Grimwood K, McIntyre P, Lambert S. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Rev Vaccines. 2014;13(9):1081-1106. https://www.tandfonline.com/doi/abs/10.1586/14760584.2014.944167
Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521-1528. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60686-3/fulltext
Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis. 2015;60(3):333-337. https://academic.oup.com/cid/article/60/3/333/415644
Healy C, Rench M, Wootton S, Castagnini L. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J. 2015;34(1):22-26. https://journals.lww.com/pidj/Abstract/2015/01000/Evaluation_of_the_Impact_of_a_Pertussis_Cocooning.6.aspx
Ministerio de Salud Pública y Bienestar Social, Paraguay. Manual de vigilancia epidemiológica de enfermedades transmisibles. 4ª ed. Asunción: MSPBS; 2021. https://www.mspbs.gov.py/dependencias/vigepi/adjunto/5c2a52-ManualdeVigilanciaEpidemiolgica2021.pdf
World Health Organization. Vaccine-preventable diseases surveillance standards: pertussis. Geneva: WHO; 2018. https://www.who.int/immunization/monitoring_surveillance/burden/vpd/WHO_SurveillanceVaccinePreventable_16_Pertussis_R2.pdf
German R, Lee L, Horan J, Milstein R, Pertowski C, Waller M. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep. 2001;50(RR-13):1-35. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm
Organización Panamericana de la Salud. Estado de la inmunización en las Américas: informe anual 2022. Washington, D.C.: OPS; 2023. https://iris.paho.org/handle/10665.2/57456
Ministerio de Salud Pública y Bienestar Social, Paraguay. Programa Ampliado de Inmunizaciones: manual normativo. 6ª ed. Asunción: MSPBS; 2022. https://www.mspbs.gov.py/dependencias/pai/adjunto/164a1d-ManualPAI2022Final.pdf
Dirección General de Estadística, Encuestas y Censos. Proyección de la población por sexo y edad, según distrito. 2000-2025. Fernando de la Mora: DGEEC; 2020. https://www.dgeec.gov.py/Publicaciones/Biblioteca/proyeccion%20nacional/Proyeccion%20Distrital.pdf
Leguizamón M, Aquino R, Báez C, Giménez G, Ortiz Z. Coberturas de vacunación en Paraguay: análisis de la Encuesta de Demografía y Salud 2016. Rev Panam Salud Publica. 2020;44:e1. https://iris.paho.org/handle/10665.2/51614
Unicef Paraguay. Análisis de situación de la inmunización en Paraguay. Asunción: Unicef; 2021. https://www.unicef.org/paraguay/informes/analisis-de-situacion-de-la-inmunizacion-en-paraguay
Ministerio de Salud de Brasil. Boletim Epidemiológico: Coqueluche - Brasil 2019-2023. Brasília: MS; 2024. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos
Ministerio de Salud de Argentina. Boletín Integrado de Vigilancia. Buenos Aires: MS; 2023. https://www.argentina.gob.ar/salud/epidemiologia/boletines
Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis. 2013;13:151. https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-151
Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, et al. California pertussis epidemic, 2010. J Pediatr. 2012;161(6):1091-1096. https://www.jpeds.com/article/S0022-3476(12)00793-2/fulltext
Secretaria de Vigilância em Saúde, Brasil. Situação epidemiológica da coqueluche no Brasil: 2010 a 2019. Bol Epidemiol. 2020;51(35):11-18. https://antigo.saude.gov.br/images/pdf/2020/setembro/09/Boletim-epidemiologico-SVS-35-aa.pdf
Ministerio de Salud de Argentina. Análisis de situación de salud: tos convulsa en Argentina 2015-2019. Buenos Aires: MS; 2020. https://bancos.salud.gob.ar/recurso/analisis-de-situacion-de-salud-tos-convulsa-en-argentina-2015-2019
Schwartz K, Kwong J, Deeks S, Campitelli M, Jamieson F, Marchand-Austin A, et al. Effectiveness of pertussis vaccination and duration of immunity. CMAJ. 2016;188(16):E399-E406. https://www.cmaj.ca/content/188/16/E399
Bisgard K, Pascual F, Ehresmann K, Miller C, Cianfrini C, Jennings C, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23(11):985-989. https://journals.lww.com/pidj/Abstract/2004/11000/Infant_pertussis_who_was_the_source.1.aspx
Vilajeliu A, García-Basteiro A, Valencia S, Bayas J. Pertussis in pregnant women and newborns: a systematic review of the global epidemiology. Expert Rev Vaccines. 2015;14(9):1279-1294. https://www.tandfonline.com/doi/abs/10.1586/14760584.2015.1057572
Carbonetti N. Pertussis toxin and adenylyl cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol. 2010;5(3):455-469. https://www.futuremedicine.com/doi/abs/10.2217/fmb.09.133
Fine E, Clarkson J. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet. 1982;1(8273):666-669. https://www.thelancet.com/journals/lancet/article/PII0140-6736(82)92214-4/fulltext
Hethcote H. An age-structured model for pertussis transmission. Math Biosci. 1997;145(2):89-136. https://www.sciencedirect.com/science/article/pii/S0025556497000144
Riffelmann M, Wirsing von König CH, Caro V, Guiso N. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol. 2005;43(10):4925-4929. https://journals.asm.org/doi/10.1128/JCM.43.10.4925-4929.2005
Mattoo S, Cherry J. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326-382. https://journals.asm.org/doi/10.1128/CMR.18.2.326-382.2005
Jajosky R, Groseclose S. Evaluation of reporting timeliness of public health surveillance systems for infectious diseases. BMC Public Health. 2004;4:29. https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-4-29
M’ikanatha N, Lynfield R, Van Beneden C, de Valk H, editores. Infectious disease surveillance. 2ª ed. Oxford: Blackwell Publishing; 2013. https://www.wiley.com/en-us/Infectious+Disease+Surveillance%2C+2nd+Edition-p-9780470654675